Inez Schoenmakers
Sun 20 10:15
SS1.1
Special Symposium: Bone & Vitamin D
Free and bound vitamin D and health outcomes.
Martin Fassnacht
Sun 20 15:15
GL1.1
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Introduction to ENSAT Guidelines
Sun 20 16:00
GL1.5
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Therapy of advanced ACC
Massimo Terzolo
Sun 20 15:45
GL1.4
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Adjuvant therapy
Martin Fassnacht
Sun 20 15:15
GL1.1
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Introduction to ENSAT Guidelines
Sun 20 16:00
GL1.5
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Therapy of advanced ACC
Harm Haak
Sun 20 16:15
GL1.6
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Special considerations on mitotane
Giovanna Mantovani
Mon 21 15:15
S19.1
Symposium 19: New Aspects of Pituitary Regulation
Cytoskeleton and pharmacologic resistance in pituitary tumours
John Todd
Tue 22 09:45
S23.1
Symposium 23: Pre-diabetes
What have we learnt so far about the immunogenetics of type 1 diabetes?
Clemens Schmitt
Tue 22 10:15
S25.2
Symposium 25: Late breaking
Senescence-associated reprogramming promotes cancer stemness
Alberto Pereira
Amsterdam, The Netherlands
Tue 22 09:45
Endo-ERN: concrete examples of added value for patient care
Introduction, structure, and virtual consultation using the EU-ERN CPMS
Amsterdam, The Netherlands
Mrs Manuela Brösamle
Tue 22 10:15
Endo-ERN: concrete examples of added value for patient care
Patient and family perspectives
Dr Scott Akker
London, UK
Tue 22 10:15
S21.2
Symposium 21: The Dance of Adrenal and Gonads
Management of phaeochromocytoma during pregnancy
London, UK
Frederique Albarel
Mon 21 16:15
S19.3
Symposium 19: New Aspects of Pituitary Regulation
How cancer treatment effects your pituitary
Krystallenia Alexandraki
Tue 22 15:45
S26.3
Symposium 26: Cortisol: Too much of a Good Thing
Differentiating Cushing from Pseudo-Cushing
Jayakumar Ambigapathy
Sun 20 12:48
OC2.5
Oral Communication: Look who is controlling your gonads!
Effect of thyroxine replacement on leydig cell and sertoli cell function in men with hypothyroidism
Karin Amrein
Sun 20 10:45
SS1.2
Special Symposium: Bone & Vitamin D
Vitamin D and Critical Care
Sof Andrikopoulos
Melbourne, Australia
Mon 21
PW1.4
Publishing Workshop
Publishing ethics
Melbourne, Australia
Anna Angelousi
Mon 21 11:20
S15.5
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Alterations in Clock genes expression in human benign adrenal tumors
Natasha Appelman
Mon 21 10:45
S12.2
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Bone quality evaluation in Pituitary diseases
Peter Arner
Tue 22 10:45
S22.3
Symposium 22: The fatty bone
Cross-talk between bone marrow and periperal adipose tissue in man
Guillaume Assié
Sun 20 15:30
GL1.3
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Pathology & Prognostic factors
Guillaume Assié
Mon 21 12:00
OC7.1
Oral Communication: Genomic and clinical aspects of endocrine tumours
Molecular classification of benign adrenocortical tumors: an integrated genomic study
Tais Assmann
Mon 21 12:12
OC8.2
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
MicroRNA expression profiling and functional annotation analysis of their targets in patients with diabetic kidney disease.
Julie Bakker
Belgium
Tue 22 15:45
S30.3
Symposium 30: Disorders of Sexual Development (DSD)
Gender Dysphoria and Brain Function
Belgium
Irina Bancos
Mon 21 12:12
OC7.2
Oral Communication: Genomic and clinical aspects of endocrine tumours
Urine steroid metabolomics as a diagnostic tool for detection of adrenocortical malignancy – a prospective test validation study
Zhanna Belaya
Tue 22 15:45
S27.3
Symposium 27: Emerging treatments in osteoporosis
Sequential and combination therapy for osteoporosis
Carlos Bernal-Mizrachi
Sun 20 11:15
SS1.3
Special Symposium: Bone & Vitamin D
Vitamin D, macrophages and atherosclerosis
Stella Bernardi
Sun 20 12:24
OC4.3
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Effects of TRAIL delivery on an experimental model of type 2 diabetes and diabetic nephropathy
Filippo Biscarini
Mon 21 12:36
OC8.4
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Detecting blood micro-RNAs and proteins associated with Graves’ disease and orbitopathy
Ulrich Boehm
Mon 21 10:15
S14.1
Symposium 14: Neuroendocrine basis of reproductive disorders
Developmental wiring of GnRH neurons
Professor Kristien Boelaert
Birmingham, UK
Tue 22
D5.1
Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
FOR - Pregnant women should be screened for thyroid hormones and antibodies
Birmingham, UK
Jens Bollerslev
Mon 21 11:15
S12.3
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Effect of parathyroid dysfunction on incidence of bone fractures
Riccardo Bonadonna
Tue 22 10:45
S23.3
Symposium 23: Pre-diabetes
Treatment of pre type 2 diabetes
Francesc Borras
Tue 22 09:45
S25.1
Symposium 25: Late breaking
Microvesicles and exosomes: new players in metabolic diseases
Philippe Bouchard
Sat 19 19:25
PL1
Plenary 1: Contraception: Past and future
Contraception: Past and future
Alexandre Buffet
Mon 21 12:36
OC7.4
Oral Communication: Genomic and clinical aspects of endocrine tumours
Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier (SLC25A11) gene confer predisposition to metastatic paragangliomas.
E Buitenwerf
Mon 21 12:48
OC7.5
Oral Communication: Genomic and clinical aspects of endocrine tumours
Randomized trial comparing phenoxybenzamine and doxazosine for preoperative treatment of patients with a pheochromocytoma (PRESCRIPT)
Biagio Cangiano
Tue 22 11:54
OC12.3
Oral Communication: Novel aspects of puberty development and Cushing's disease
Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism
Albert Cano
Tue 22 12:18
OC14.5
Oral Communication: What is new in gestational and type 1 diabetes?
Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine
Philippe Caron
Sun 20 12:00
OC1.1
Oral Communication: Benign thyroid diseases
Familial gestational hyperthyroidism caused by Val597Ile mutant of TSH receptor gene with human chorionic gonadotropin hypersensitivity
Isadora Cavalcante
Mon 21 12:48
OC5.5
Oral Communication: Diving deep into adrenal cortex diseases
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Dr William Cawthorn
Edinburgh , Scotland
Tue 22 10:15
S22.2
Symposium 22: The fatty bone
Bone marrow adipose tissue: starving for attention?
Edinburgh , Scotland
Giovanni Ceccarini
Mon 21 15:45
S20.2
Symposium 20: All you need to know about lipodystrophy
Acquired forms of lipodystrophy
Philippe Chanson
Paris, France
Mon 21 17:15
CET1
Clinical Endocrinology Trust Lecture - Growth Hormone: not too much...not too less!
Growth Hormone: not too much...not to less!
Paris, France
Kristina Chen
Sun 20 12:36
OC3.4
Oral Communication: New insights in bone disorders
Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy
Irina Chifu
Mon 21 12:36
OC5.4
Oral Communication: Diving deep into adrenal cortex diseases
Assessment of Tissue Sodium Content by 23Na-MRI in Patients with Adrenal Insufficiency – a Pilot Study
Luca Chiovato
Sun 20 10:45
S1.2
Symposium 1: Predicting events in autoimmune thyroid disease
IgG4 related thyroid autoimmune disease
Mon 21
D3.1
Debate 3: Subclinical hypothyroidism is a disease
FOR - Subclinical hypothyroidism is a disease
Ioana Chisalita
Sun 20 12:12
OC4.2
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Toe brachial index predicts major adverse cardiovascular events in patients with type 2 diabetes
Sun Cho
Korea, Republic of
Mon 21 12:12
OC9.2
Oral Communication: Thyroid from basics to clinics
Anti-tumoral effects of metformin on metastatic bone lesions of thyroid cancer
Korea, Republic of
Thomas Clemens
Tue 22 14:45
S27.1
Symposium 27: Emerging treatments in osteoporosis
Molecular basis of bone anabolism
Sabrina Corbetta
Mon 21 12:24
OC7.3
Oral Communication: Genomic and clinical aspects of endocrine tumours
IncRNAs profiling reveals epigenetic heterogeneity among human parathyroid tumor
Giovanni Corona
Sun 20 16:15
S9.3
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Does "healthy obesity" exist in andrology? 
Professor Sabine Costagliola
Brussels, Belgium
Tue 22
NSA6
New Scientific Approach 6 - Functional thyroid in the dish
Functional thyroid in the dish
Brussels, Belgium
Mr Sherwin Criseno
Birmingham , United Kingdom
Sun 20 11:15
N1.3
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Witty - The Role of Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathy
Birmingham , United Kingdom
Guido Dalmazi
Mon 21 12:12
OC5.2
Oral Communication: Diving deep into adrenal cortex diseases
Steroid profiling by liquid chromatography tandem mass spectrometry in a large cohort of patients with adrenal incidentalomas
Jaap Deinum
Sun 20
D1.2
Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Against - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Olaf Dekkers
Sun 20 15:20
GL1.2
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Methods
Didier Dewailly
Mon 21 12:15
D4.1
Debate 4: AMH as the Primary Marker for Fertility
FOR - AMH as the Primary Marker for Fertility
Maeve Durkan
Sun 20
UEM1.1
UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
News from Brussels
Tina Dusek
Mon 21
MTE8
Meet The Expert 8 - Hormone replacement for the travelling patient
Hormone replacement for the travelling patient
Grigoris Effraimidis
Sun 20 10:15
S1.1
Symposium 1: Predicting events in autoimmune thyroid disease
The THEA score in familial thyroid dysfunction
Rossella Elisei
Mon 21 16:15
S16.3
Symposium 16: Changing practice in the management of thyroid neoplasms
New classification and guidelines in differentiated thryroid cancers
Murat Erdogan
Mon 21 15:45
S16.2
Symposium 16: Changing practice in the management of thyroid neoplasms
Composite approach in the evaluation and management of thyroid nodule
Eduardo Eyras
Sun 20 14:00
NSA2
New Scientific Approach 2 - The spliceosome as a target treatment of endocrine tumours
The spliceosome as a target treatment of endocrine tumours
Judith Favier
Mon 21 10:40
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Epigenetic and metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas
Ulla Feldt-Rasmussen
Mon 21
D3.2
Debate 3: Subclinical hypothyroidism is a disease
AGAINST - Subclinical hypothyroidism is a disease
Tiziana Feola
Tue 22 12:06
OC13.4
Oral Communication: The curious case of growth hormone
Effects of Pegvisomant on Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies
Anna Ferrulli
Mon 21 12:12
OC6.2
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
DEEP TRANSCRANIAL MAGNETIC STIMULATION ACUTELY MODULATES NEURO-ENDOCRINE PATHWAYS UNDERLYING OBESITY
Jose. Florez
Sun 20 15:15
S6.1
Symposium 6: Precision Medicine for diabetes
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Ines Foessl
Mon 21 12:48
OC8.5
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
MicroRNA profiles in diabetic octogenarians with and without historical and prospective hip fractures
Renata Frazao
Tue 22 11:30
OC12.1
Oral Communication: Novel aspects of puberty development and Cushing's disease
Growth hormone signaling in leptin receptor expressing cells, but not in Kiss1 expressing neurons, regulates the timing of puberty
Jérôme Frenette
Sun 20 12:12
OC3.2
Oral Communication: New insights in bone disorders
Can a bone protein protect against muscular dystrophy?
Isadora Furigo
Tue 22 12:18
OC13.5
Oral Communication: The curious case of growth hormone
Growth hormone acts in AGRP neurons to control energy expenditure during food restriction and promotes counter-regulatory responses to hypoglycemia via the ventromedial hypothalamus
Manuel Gahete
Sun 20 08:00
MTBS1
Meet The Expert - Basic Scientist 1: Mouse models in endocrine tumors
Mouse models in endocrine tumors
Mon 21 11:40
S15.6
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Invitation to EYES networking and annual meeting
Simona Galoiu
Tue 22 11:42
OC13.2
Oral Communication: The curious case of growth hormone
Time trends of mortality in patients with GH secreting and non-functioning pituitary adenoma.
Alessandra Gambineri
Mon 21 15:15
S18.1
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Sex hormones, obesity and type 2 diabetes – is there a link?
Carles Gaston-Massuet
London, UK
Mon 21 10:15
S11.1
Symposium 11: Novel aspects of Craniopharyngioma
Molecular Pathogenensis of Craniopharyngioma
London, UK
Laura Gathercole
Sun 20 10:45
S3.2
Symposium 3: Bile Acid and Microbiota
5β-reductase, bile acid synthesis, and the control of energy metabolism
Carmen Georgescu
Tue 22
MTE11
Meet The Expert 11 - How to integrate PCSk9 inhibitors into hyperlipademia management
How to integrate PCSk9 inhibitors into hyperlipademia management
Balázs Gereben
Tue 22 14:45
S29.1
Symposium 29: Thyroid hormone action: regulation and clinical implications
Tissue-specific regulation of thyroid hormone action
Glenn. Gerhard
Sun 20 11:15
S3.3
Symposium 3: Bile Acid and Microbiota
Bile acids and metabolic effects of bariatric surgery
Michal Gershinsky
Tue 22 12:18
OC10.5
Oral Communication: Cardiovascular aspects of endocrine diseases
Increased Risk of Antithyroid Drug-induced Agranulocytosis with Amiodarone
Paolo Giacobini
Milan, Italy
Mon 21
NSA4
New Scientific Approach 4 - 3D visualisation of the HPG axis in mice and humans
3D visualisation of the HPG axis in mice and humans
Milan, Italy
Nigel Glynn
Tue 22
MTE15
Meet The Expert 15 - Your emergency consult about hyponatraemia
Your emergency consult about hyponatraemia
Cristian González-Guerrero
Mon 21 12:00
OC9.1
Oral Communication: Thyroid from basics to clinics
Increased urinary iodine precedes hypothyroidism in Dehal1 knockout mice
Riccarda Granata
Tue 22 10:15
S24.2
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
Peripheral Activities of Growth Hormone-Releasing Hormone (GHRH)
Niels Grarup
Sun 20 11:15
S2.3
Symposium 2: Salt and Sweet
Sweet preference induced by FGF21
Stefan Groeneweg
Sun 20 15:15
S7.1
Symposium 7: Expanding the spectrum of thyroid hormone use
TRIAC Trial in Allan-Herndon-Dudley-Syndrome (MCT8)
Jörg Gromoll
Sun 20 10:45
S5.2
Symposium 5: The role of sperm epigenome in fertility and inheritance
Epigenetic germline mosaicism in infertile men
Leif Groop
Sun 20 15:45
S6.2
Symposium 6: Precision Medicine for diabetes
Can genetics improve precision medicine in diabetes?
Dr Annette Grüters-Kieslich
Copenhagen, Denmark
Tue 22 15:45
S29.3
Symposium 29: Thyroid hormone action: regulation and clinical implications
Elevated TSH in Children
Copenhagen, Denmark
Leo Guasti
Mon 21
NSA3
New Scientific Approach 3 - Re-Programming Strategies to Obtain Functional Endocrine Units
Re-Programming Strategies to Obtain Functional Endocrine Units
Jean-Pierre Hardelin
Mon 21 10:45
S14.2
Symposium 14: Neuroendocrine basis of reproductive disorders
Neuroendocrinology right from the nose: genetics and pathophysiology of the olfacto-genital syndrome (Kallmann syndrome)
Michael Hauschild
Sun 20 12:00
N2.1
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Key Note Speaker: Principles and models of Transition – an overview
Diana Heemst
Leiden, The Netherlands
Tue 22 15:15
S29.2
Symposium 29: Thyroid hormone action: regulation and clinical implications
Thyroid hormone economy in human aging
Leiden, The Netherlands
Laszlo Hegedus
Tue 22
PL6
Plenary 6: Does therapy for thyroid dysfunction decrease mortality?
Does therapy for thyroid dysfunction decrease mortality?
Per Hellman
Sun 20
D1.1
Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
For - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Violeta Heras
Sun 20 12:36
OC2.4
Oral Communication: Look who is controlling your gonads!
Novel Role of Central Ceramide Signaling in Mediating Obesity-Induced Precocious Puberty
Professor Allan Herbison
Cambridge, UK
Sun 20 17:15
PL3
Plenary 3 - The wonder world of GnRH neurons - cracking the pulse generator
The wonder world of GnRH neurons - cracking the pulse generator
Cambridge, UK
Wouter Herder
Mon 21
PW1.3
Publishing Workshop
How to select your journal and submit your paper
Olaf Hiort
Lübeck, Germany
Tue 22 10:00
Endo-ERN: concrete examples of added value for patient care
Caring for endocrinology across the life span: DSD and Hypogonadotropic hypogonadism
Lübeck, Germany
Ewout Hoorn
Sun 20 10:15
S2.1
Symposium 2: Salt and Sweet
Hyponatremia and mortality: moving beyond associations
Kai-Lun Hu
Sun 20 12:12
OC2.2
Oral Communication: Look who is controlling your gonads!
Overexpressed kisspeptin/Kiss1R system in human granulosa cells may be involved in the pathogenesis of polycystic ovary syndrome (PCOS) by inhibiting ovulation.
Professor Ilpo Huhtaniemi
London, UK
Mon 21
EHM1
European Hormone Medal Lecture - Unraveling secrets of the hypothalami-pituitary-gonadal axis
Unraveling secrets of the hypothalamic-pituitary-gonadal axis
London, UK
Peter Igaz
Tue 22
NSA5
New Scientific Approach 5 - Circulating miRNAs in Endocrine Tumours
Circulating miRNAs in Endocrine Tumours
Tatjana Isailovic
Mon 21 10:15
S15.1
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Introduction to EYES
Tue 22 11:54
OC11.3
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Clinical and histopathological differences between MEN1 carriers and MEN1 phenocopy patients
Iva Jakubíková
Mon 21 12:24
OC9.3
Oral Communication: Thyroid from basics to clinics
A mouse model of BRAF V600E mutated papillary thyroid cancer imitating sporadic conditions
Inés Jimenez
Tue 22 12:06
OC10.4
Oral Communication: Cardiovascular aspects of endocrine diseases
Improvement in the control of hypertension in diabetic patients screened for hyperaldosteronism
Mireia Jordà
Mon 21 12:36
OC9.4
Oral Communication: Thyroid from basics to clinics
Identification of an epigenetic biomarker panel for predicting the development of distant metastases in differentiated thyroid cancer
Dr. Niels Jørgensen
Copenhagen, Denmark
Sun 20 15:15
S9.1
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Semen parameters as biomarkers of general health  
Copenhagen, Denmark
Anne Jouinot
Tue 22 11:42
OC11.2
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma
Nicolas Kalfa
Tue 22 15:15
S30.2
Symposium 30: Disorders of Sexual Development (DSD)
Atypical Genital Development and Hypospadias: a Pediatric Urology perspective from Etiology to Surgery
Gregory Kaltsas
Tue 22
MTE12
Meet The Expert 12 - Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
Małgorzata Kałużna
Tue 22 11:42
OC12.2
Oral Communication: Novel aspects of puberty development and Cushing's disease
Oligogenicity in Kallmann syndrome - an underestimated phenomenon?
Peter Kamenický
Sun 20 12:00
OC3.1
Oral Communication: New insights in bone disorders
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Burosumab, an Anti-FGF23 Antibody, In Adult X-Linked Hypophosphatemia (XLH)
Daniel Kaplan
Tue 22 10:45
S25.3
Symposium 25: Late breaking
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Niki Karavitaki
Birmingham, UK
Sun 20 10:45
N1.2
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Bad - Immunotherapy-induced Endocrinopathy
Birmingham, UK
Jean Kaufman
Mon 21 16:15
S18.3
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Testosterone, obesity and the metabolic syndrome in males – do we need to replace steroids?
Dr Punith Kempegowda
Birmingham, UK
Mon 21 11:00
S15.4
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Immune Checkpoint Inhibitor Induced Hypophysitis – Experiences from the United Kingdom
Birmingham, UK
Patimat Khandaeva
Mon 21 12:00
OC8.1
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Plasma microRNA expression in patients with Cushing’s disease differs from ACTH-ectopic Cushing’s syndrome.
Florian Kiefer
Mon 21 10:45
S13.2
Symposium 13: The colours of fat
Adipose Tissue Browning in Mice and Men
Filip Knop
Sat 19 18:50
EJE1
EJE Prize Lecture - A gut feeling about glucagon
A gut feeling about glucagon
Josef Köhrle
Mon 21
PW1.5
Publishing Workshop
Data presentation, precision and ‘pseudoprecision’
Dr Tim Korevaar
Netherlands, Netherlands
Sun 20
UEM1.3
UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
UEMS 3E Grant Presentation: Endocrine disruptors and thyroid function during pregnancy
Netherlands, Netherlands
Beata Kos-Kudła
Mon 21
PW1.1
Publishing Workshop
Introduction from the Chair
Noora Kotaja
Sun 20 10:15
S5.1
Symposium 5: The role of sperm epigenome in fertility and inheritance
The quality control of the male germline transcriptome
Stravroula Kousteni
Sun 20 09:15
PL2
Plenary 2 - Bone regulates the Brain
Bone regulates the Brain
J.C. Kralingen
Mon 21 12:24
OC8.3
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Circulating Levels of microRNAs Associate with Blood Pressure and Left Ventricular Mass in Primary Hypertensive Patients
Csilla Krausz
Sun 20 12:24
OC2.3
Oral Communication: Look who is controlling your gonads!
Whole exome sequencing in non-obstructive azoospermia allows the identification of a high-risk subgroup of infertile men for undiagnosed Fanconi Anemia, a cancer-prone disease.
Michal Kršek
Sun 20 08:00
MTE2
Meet The Expert 2 - Acromegaly: Optimal management after surgery
Acromegaly: Optimal management after surgery
Maxime Kwapich
Mon 21 12:24
OC6.3
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Visceral fat assessment in lamin A/C mutation carriers: Phenotype-Genotype correlation
Andre Lacroix
Tue 22 12:06
OC12.4
Oral Communication: Novel aspects of puberty development and Cushing's disease
Late-night salivary cortisol (LNSC) levels in a Phase III study of long-­acting pasireotide in patients with Cushing’s disease (CD)
Joop Laven
Mon 21 12:15
D4.2
Debate 4: AMH as the Primary Marker for Fertility
AGAINST - AMH as the Primary Marker for Fertility
Rossella Libe
Mon 21 15:45
S17.2
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Genetics of Primary Adrenal Macronodular Hyperplasia: when and what to test
Dr Sofia Llahana
London, UK
Sun 20 12:40
N2.4
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Transition in Hypogonadism
London, UK
Mon 21 15:15
N4.1
Nurses professional development, networking session and oral/poster presentations
Welcome and update on ESE nurse activties
London, UK
Michal Lotem
Tue 22 14:45
S28.1
Symposium 28: Endocrinology Meets Immunology
Concept of Immunotherapy in Cancer
Mario Maggi
Tue 22
MTE13
Meet The Expert 13 - Erectile Dysfunction
Erectile Dysfunction
Ana Maia
Sun 20 08:00
MTE5
Meet The Expert 5 - Medullary thyroid cancer beyond surgery
Medullary thyroid cancer beyond surgery
Outi Mäkitie
Helsinki, Finland
Sun 20 15:15
S8.1
Symposium 8: Bone fragility – from bench to clinic
Clinical spectrum of new monogenic forms of osteoporosis
Helsinki, Finland
Maria Malagon
Mon 21 15:45
S19.2
Symposium 19: New Aspects of Pituitary Regulation
What fat does with your pituitary
Christos Mantzoros
Sat 19 18:15
GH1
Geoffrey Harris Lecture - Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Monica Marazulea
Sun 20
D2.2
Debate 2 - Receptor profiling is useful for predicting pituitary therapy
Against - Receptor profiling is useful for predicting pituitary therapy
Hanns-Ulrich Marschall
Sun 20 10:15
S3.1
Symposium 3: Bile Acid and Microbiota
Crosstalk between bile acids and intestinal microbiota - influence on host metabolism
Blazej Meczekalski
Tue 22 10:45
S21.3
Symposium 21: The Dance of Adrenal and Gonads
Fertility in Congenital Adrenal Hyperplasia
Emese Mezosi
Mon 21
MTE7
Meet The Expert 7 - Difficult cases of differentiated thyroid cancer
Difficult cases of differentiated thyroid cancer
Lina Michala
Tue 22 14:45
S30.1
Symposium 30: Disorders of Sexual Development (DSD)
Long term consequences of Disorders of Sexual Development
Irene Mitchelhill
Sun 20 12:30
N2.2
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Paediatric to adult transition in Endocrinology
Mon 21 12:00
N3.1
Meet the Nurse Expert & Case Discussions
Nursing Management of CAH: Education & Use of Multi-media Technology
Lars Moeller
Essen, Germany
Tue 22
MTBS3
Meet The Expert - Basic Scientist 3: Watch out for noncanonical mechanisms of thyroid hormone action!
Watch out for noncanonical mechanisms of thyroid hormone action!
Essen, Germany
Niels Moeller
Tue 22 10:45
S24.3
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
How Do Hypopituitary Patients Deal with Stress?
Patrice Mollard
Montpellier, France
Tue 22 09:45
S24.1
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
How Does Pituitary Release its Hormones?
Montpellier, France
Beatriz Moreno
Sun 20 12:12
OC1.2
Oral Communication: Benign thyroid diseases
Relationship between TSH values in the first trimester of pregnancy and obstetric and neonatal complications
Sharon Munn
Tue 22
D6.2
Debate 6: Endocrine disruptors: Regulatory vs. Scientific Perspectives
REGULATORY - Endocrine disruptors: Regulatory vs. Scientific Perspectives
Nicola Napoli
Mon 21 10:15
S12.1
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Increased fracture rate in diabetes and obesity      
Narjes Nasiri-Ansari
Tue 22 11:42
OC10.2
Oral Communication: Cardiovascular aspects of endocrine diseases
Canagliflozin attenuates the progression of atherosclerosis via reducing hyperlipidaemia and inflammation process in ApoE KO Mice
João Neves
Sun 20 12:48
OC1.5
Oral Communication: Benign thyroid diseases
Low free T3 levels within the reference range independently predict cardiovascular mortality in the general population
Sun 20 12:36
OC4.4
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Association between prediabetes and incidence of chronic kidney disease, incident albuminuria, or worsening of kidney function: a secondary analysis of the SPRINT trial
Professor John Newell-Price
Sheffield, UK
Tue 22
MTE16
Meet The Expert 16 - Adrenal incidentaloms
Adrenal incidentaloms
Sheffield, UK
Professor Eberhard Nieschlag
Münster, Germany
Sun 20 15:45
S9.2
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
The Klinefelter syndrome: a challenge for endocrinologists 
Münster, Germany
Nikolaos Nikolaou
Oxford, United Kingdom
Mon 21 12:00
OC6.1
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
5β-reductase (AKR1D1) is a potent regulator of hepatic insulin sensitivity, carbohydrate and lipid metabolism in vitro and in vivo
Oxford, United Kingdom
Ruben Nogueiras
Mon 21 11:15
S14.3
Symposium 14: Neuroendocrine basis of reproductive disorders
Metabolic-reproductive interactions: From bench to bedside
Pirjo Nuutila
Mon 21 11:15
S13.3
Symposium 13: The colours of fat
Brown Adipose Tissue Imaging
Nicolás Olea
Tue 22
D6.1
Debate 6: Endocrine disruptors: Regulatory vs. Scientific Perspectives
SCIENCE - Endocrine disruptors: Regulatory vs. Scientific Perspectives
Daniel Olsson
Mon 21 10:45
S11.2
Symposium 11: Novel aspects of Craniopharyngioma
Bariatric Surgery as Treatment in Craniopharyngioma
José Ordovas
Sun 20 16:15
S6.3
Symposium 6: Precision Medicine for diabetes
Precision nutrition in obesity: gene - diet interaction
Lisa Owens
Sun 20 12:00
OC2.1
Oral Communication: Look who is controlling your gonads!
The in vivo and in vitro effects of kisspeptin on human ovarian function
Anna Papadopoulou
Tue 22 11:42
OC14.2
Oral Communication: What is new in gestational and type 1 diabetes?
Profiling of activation patterns of placental mTOR in pregnancies complicated by gestational diabetes mellitus
Marianne Pavel
Sun 20 15:45
S10.2
Symposium 10: Hot topics in NETs
Treatment of small intestine and pancreatic NETs what and when?
Arkaitz Perez
Mon 21 10:20
S15.2
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Metabolic reprogramming of cancer cells
Duarte Pignatelli
Tue 22 09:45
S21.1
Symposium 21: The Dance of Adrenal and Gonads
The interplay Between the Ovaries and Adrenals
Stefan Pilz
Tue 22
MTE14
Meet The Expert 14 - Vitamin D for everybody
Vitamin D for everybody?
Mark Postma
Tue 22 11:30
OC13.1
Oral Communication: The curious case of growth hormone
Postoperative use of somatostatin analogs and mortality in patients with acromegaly.
Rachel Powell
Sun 20 10:15
N1.1
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Good- Overview and Indications of Immunotherapy in Oncology
Manuel Puig-Domingo
Tue 22 11:54
OC13.3
Oral Communication: The curious case of growth hormone
Molecular profiling for assistance to pharmacological treatment of acromegaly
Efisio Puxeddu
Tue 22 15:15
S28.2
Symposium 28: Endocrinology Meets Immunology
Immunotherapy for Thyroid Carcinoma
Tilman Rachner
Tue 22 15:15
S27.2
Symposium 27: Emerging treatments in osteoporosis
Novel therapies: PTH-related protein and sclerostin inhibition
Rachida Rafiq
Mon 21 12:48
OC6.5
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Associations of different body fat deposits with serum 25-hydroxyvitamin D concentrations
Taneli Raivio
Helsinki, Finland
Sun 20 08:00
MTE3
Meet The Expert 3 - Managing delayed puberty
Managing delayed puberty
Helsinki, Finland
Laura Ramírez
Tue 22 14:45
S26.1
Symposium 26: Cortisol: Too much of a Good Thing
Genetics of Cushing's disease
Garcilaso Riesco-Eizaguirre
Mon 21 15:15
S16.1
Symposium 16: Changing practice in the management of thyroid neoplasms
Genomic alterations in thyroid malignancies
Mercedes Rio-Moreno
Sun 20 12:00
OC4.1
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Dietary intervention modulates the expression of the splicing machinery in patients at high-risk of type 2 diabetes development: clinical implications
Fernando Rivadeneira
Sun 20 15:45
S8.2
Symposium 8: Bone fragility – from bench to clinic
What have we learnt from genome-wide association studies in osteoporosis
Karine Rizzoti
London, UK
Mon 21
MTEBS2
Meet the Expert - Basic Scientist 2 -Single-cell sequencing in endocrine diseases
Single-cell sequencing in endocrine diseases
London, UK
Graham Roberts
Waterford, Ireland
Sun 20
UEM1.2
UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
ESE/UEMS European Board Examination in Endocrinology, Diabetes and Metabolism
Waterford, Ireland
Hans Romijn
Mon 21
PW1.2
Publishing Workshop
Responding to reviewer comments
Dr Cristina Ronchi
Birmingham, United Kingdom
Tue 22 11:30
OC11.1
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication.​
Birmingham, United Kingdom
Maria Rotkank
Tue 22 12:06
OC14.4
Oral Communication: What is new in gestational and type 1 diabetes?
The variability of glycemia and the metabolic composition of brain cells in patients with type 1 diabetes mellitus
Alina Rozanska
Mon 21 15:45
N4.3
Nurses professional development, networking session and oral/poster presentations
Role of the Endocrine nurse in the MDT in improving care for patients with thyroid cancer
Jonas Rutishauser
Sun 20 10:45
S2.2
Symposium 2: Salt and Sweet
Hereditary Diabetes insipidus
Elisa Sala
Tue 22 12:18
OC11.5
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Natural history of Rathke’s Cleft Cysts: a multicenter experience
Enric Sánchez
Sun 20 12:48
OC4.5
Oral Communication: Novel insights into prediabetes and type 2 diabetes
The impact of prediabetes in lung function: data from the ILERVAS project
Ilhan Satman
Mon 21
MTE6
Meet The Expert 6 - Long term implications of hypoglycaemia in diabetes
Long term implications of hypoglycaemia in diabetes
David Savage
Mon 21 15:15
S20.1
Symposium 20: All you need to know about lipodystrophy
Insights in the pathogenesis of lipodystrophy
Mesut Savas
Mon 21 12:36
OC6.4
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Anthropometric measurements and metabolic syndrome in relation to glucocorticoid receptor polymorphisms in (local) corticosteroid users
Silviu Sbiera
Tue 22 12:06
OC11.4
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Update in the genetic landscape of Cushing’s Disease: TP53 and a new deubiquitinase in spotlight
Kathrin Schmohl
Sun 20 15:45
S7.2
Symposium 7: Expanding the spectrum of thyroid hormone use
Tetrac as an antiangiogenic agent in cancer
Carsten Schultz
Sun 20
NSA1
New Scientific Approach 1 - New tools for investigating insulin secretion
New tools for investigating insulin secretion
Tim Schulz
Tue 22 09:45
S22.1
Symposium 22: The fatty bone
Marrow adipose tissue and skeletal health
Lothar Seefried
Sun 20 16:15
S8.3
Symposium 8: Bone fragility – from bench to clinic
Hypophosphatasia
Manuel Serrano
Tue 22 17:15
PL7
Plenary 7: Metabolic control of longevity
Metabolic control of longevity
Gerald Shulman
Mon 21
PL5
Plenary 5: The link between insulin and fatty liver
The link between insulin and fatty liver
Rafael Simo
Mon 21
PL4
Plenary 4 - The Retina as a Window for Exploring the Brain in Diabetes
The Retina as a Window for Exploring the Brain in Diabetes
Jakob Skov
Tue 22 11:30
OC10.1
Oral Communication: Cardiovascular aspects of endocrine diseases
Glucocorticoid replacement-doses and cardiovascular events in autoimmune Addison’s disease – a population based retrospective cohort study.
Marieke Snel
Sun 20 12:24
OC1.3
Oral Communication: Benign thyroid diseases
Thyroid hormone replacement therapy for subclinical hypothyroidism in adults: systematic review and meta-analysis of randomized-controlled trials
Ana Sousa
Sun 20 11:15
S4.3
Symposium 4: Environmental Effects on Endocrine Function
Environmental contaminants and endocrine disruption: The story of obesogens
Helen Spoudeas
Mon 21 11:15
S11.3
Symposium 11: Novel aspects of Craniopharyngioma
Psychosocial dysfunction after treatment of of Craniopharyngioma
Dr Karla Suchacki
Edinburgh, UK
Sun 20 12:24
OC3.3
Oral Communication: New insights in bone disorders
[18F]-FDG PET/CT imaging: A tool to reveal the metabolic functions of bone marrow adipose tissue
Edinburgh, UK
Mirjana Sumarac-Dumanovic
Mon 21 15:45
S18.2
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Relevant therapies in PCOS
Francesco Tecilazich
Tue 22 11:54
OC14.3
Oral Communication: What is new in gestational and type 1 diabetes?
Patrolling monocytes are activated in diabetes and provide protection to retinal vessels in the context of leukostasis.
Malgorzata Trofimiuk-Muldner
Sun 20 12:36
OC1.4
Oral Communication: Benign thyroid diseases
The Impact of Obligatory Iodine Prophylaxis on Thyroid Volume in Schoolchildren
Malgorzata Trofimiuk-Müldner
Sun 20 10:45
S4.2
Symposium 4: Environmental Effects on Endocrine Function
Iodine deficiency in pregnancy and development of offspring
Guy T'Sjoen
Mon 21
MTE10
Meet The Expert 10 - Effects of gender-affirming hormone therapy on bone in transgender persons
Effects of gender-affirming hormone therapy on bone in transgender persons
Pierre Val
Mon 21 15:15
S17.1
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Adrenal development and benign tumor formation
Elena Valassi
Tue 22 12:18
OC12.5
Oral Communication: Novel aspects of puberty development and Cushing's disease
Diabetes mellitus and muscle weakness are independently associated with mortality in patients with Cushing's syndrome. Data from ERCUSYN.
Mark Vanderpump
Tue 22 15:45
S28.3
Symposium 28: Endocrinology Meets Immunology
Immunotherapy Related Endocrinopathies
Dirk Vanderschueren
Sun 20 08:00
MTE4
Meet The Expert 4 - Osteoporosis in men
Osteoporosis in men
Dimitra Vassiliadi
Mon 21 16:15
S17.3
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Diagnosis and management of Primary Adrenal Macronodular Hyperplasia
Tanya Vavouri
Sun 20 11:15
S5.3
Symposium 5: The role of sperm epigenome in fertility and inheritance
Mechanisms of epigenetic inheritance through sperm: lessons we have learnt from model organisms
Brigitte Velkeniers
Tue 22
D5.2
Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
AGAINST - Pregnant women should be screened for thyroid hormones and antibodies
David Vilar
Mon 21 16:15
S20.3
Symposium 20: All you need to know about lipodystrophy
Lipodystrophies, diagnosis and treatment: a step-by-step approach
Francesc Villarroya
Mon 21 10:15
S13.1
Symposium 13: The colours of fat
Brown adipose tissue as an endocrine organ
Svetlana Vujovic
Mon 21
MTE9
Meet The Expert 9 - Premature ovarian failure: an endocrine perspective
Premature ovarian failure: an endocrine perspective
Cheryl Walker
Sun 20 10:15
S4.1
Symposium 4: Environmental Effects on Endocrine Function
Developmental Reprogramming of the Epigenome by Endocrine Disrupting Chemicals that Increase Cancer Risk
Nicolaas Wee
Tue 22 15:15
S26.2
Symposium 26: Cortisol: Too much of a Good Thing
Hypercortisolism and the Brain
Isabel Weigand
Mon 21 12:24
OC5.3
Oral Communication: Diving deep into adrenal cortex diseases
PRKACA L206R mutation in adrenal Cushing’s syndrome makes PKA RIIβ susceptible for caspase-mediated cleavage
Staffan Welin
Sun 20 16:15
S10.3
Symposium 10: Hot topics in NETs
Treatment update on carcinoid syndrome and carcinoid heart disease
Chantal Wiepjes
Amsterdam, The Netherlands
Sun 20 12:48
OC3.5
Oral Communication: New insights in bone disorders
Change in bone mineral density during the first 10 years of gender affirming hormonal treatment in transwomen and transmen
Amsterdam, The Netherlands
Tracy Williams
Mon 21 12:00
OC5.1
Oral Communication: Diving deep into adrenal cortex diseases
Is adrenal computed tomography accurate for the diagnosis of unilateral primary aldosteronism? A retrospective international cohort study
Marcela Xhindi
Mon 21 16:00
N4.4
Nurses professional development, networking session and oral/poster presentations
Influence of educational training course in improving knowledge of diabetes mellitus among nurses
Cristine Yedinak
Sun 20 12:35
N2.3
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Transition between settings: hospital to community
Paul Yen
Sun 20 16:15
S7.3
Symposium 7: Expanding the spectrum of thyroid hormone use
New applications of thyroid hormones, analogs, and metabolites in non-alcoholic fatty liver
Dr Philip Yeoh
London, UK
Mon 21 15:30
N4.2
Nurses professional development, networking session and oral/poster presentations
Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance test with two different doses
London, UK
Milos Zarkovic
Sun 20 11:15
S1.3
Symposium 1: Predicting events in autoimmune thyroid disease
New scores for the prediction of Graves' disease
Maria Zatelli
Sun 20
D2.1
Debate 2 - Receptor profiling is useful for predicting pituitary therapy
For - Receptor profiling is useful for predicting pituitary therapy
Anette Ziegler
Tue 22 10:15
S23.2
Symposium 23: Pre-diabetes
Prevention and treatment of pre type 1 diabetes
Mihail Zilbermint
Tue 22 11:54
OC10.3
Oral Communication: Cardiovascular aspects of endocrine diseases
ARMC5 variants and risk of hypertension in African Americans: Minority Health-GRID study
Sat 19 18:15
GH1
Geoffrey Harris Lecture - Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Sat 19 18:50
EJE1
EJE Prize Lecture - A gut feeling about glucagon
A gut feeling about glucagon
Sun 20 08:00
MTE1
Meet The Expert 1 - Using diabetes technologies to improve pateint self care
Using diabetes technologies to improve pateint self care
Sun 20 10:15
S3.1
Symposium 3: Bile Acid and Microbiota
Crosstalk between bile acids and intestinal microbiota - influence on host metabolism
Sun 20 10:45
S3.2
Symposium 3: Bile Acid and Microbiota
5β-reductase, bile acid synthesis, and the control of energy metabolism
Sun 20 11:15
S3.3
Symposium 3: Bile Acid and Microbiota
Bile acids and metabolic effects of bariatric surgery
Sun 20
NSA1
New Scientific Approach 1 - New tools for investigating insulin secretion
New tools for investigating insulin secretion
Sun 20 15:15
S6.1
Symposium 6: Precision Medicine for diabetes
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Sun 20 15:45
S6.2
Symposium 6: Precision Medicine for diabetes
Can genetics improve precision medicine in diabetes?
Sun 20 16:15
S6.3
Symposium 6: Precision Medicine for diabetes
Precision nutrition in obesity: gene - diet interaction
Mon 21
MTE6
Meet The Expert 6 - Long term implications of hypoglycaemia in diabetes
Long term implications of hypoglycaemia in diabetes
Mon 21
PL4
Plenary 4 - The Retina as a Window for Exploring the Brain in Diabetes
The Retina as a Window for Exploring the Brain in Diabetes
Mon 21 10:15
S13.1
Symposium 13: The colours of fat
Brown adipose tissue as an endocrine organ
Mon 21 10:45
S13.2
Symposium 13: The colours of fat
Adipose Tissue Browning in Mice and Men
Mon 21 11:15
S13.3
Symposium 13: The colours of fat
Brown Adipose Tissue Imaging
Mon 21 15:15
S20.1
Symposium 20: All you need to know about lipodystrophy
Insights in the pathogenesis of lipodystrophy
Mon 21 15:45
S20.2
Symposium 20: All you need to know about lipodystrophy
Acquired forms of lipodystrophy
Mon 21 16:15
S20.3
Symposium 20: All you need to know about lipodystrophy
Lipodystrophies, diagnosis and treatment: a step-by-step approach
Mon 21
PL5
Plenary 5: The link between insulin and fatty liver
The link between insulin and fatty liver
Tue 22
MTE11
Meet The Expert 11 - How to integrate PCSk9 inhibitors into hyperlipademia management
How to integrate PCSk9 inhibitors into hyperlipademia management
Tue 22 09:45
S23.1
Symposium 23: Pre-diabetes
What have we learnt so far about the immunogenetics of type 1 diabetes?
Tue 22 10:15
S23.2
Symposium 23: Pre-diabetes
Prevention and treatment of pre type 1 diabetes
Tue 22 10:45
S23.3
Symposium 23: Pre-diabetes
Treatment of pre type 2 diabetes
Sat 19 19:25
PL1
Plenary 1: Contraception: Past and future
Contraception: Past and future
Sun 20 08:00
MTE3
Meet The Expert 3 - Managing delayed puberty
Managing delayed puberty
Helsinki, Finland
Sun 20 10:15
S5.1
Symposium 5: The role of sperm epigenome in fertility and inheritance
The quality control of the male germline transcriptome
Sun 20 10:45
S5.2
Symposium 5: The role of sperm epigenome in fertility and inheritance
Epigenetic germline mosaicism in infertile men
Sun 20 11:15
S5.3
Symposium 5: The role of sperm epigenome in fertility and inheritance
Mechanisms of epigenetic inheritance through sperm: lessons we have learnt from model organisms
Sun 20 15:15
S9.1
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Semen parameters as biomarkers of general health  
Copenhagen, Denmark
Sun 20 15:45
S9.2
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
The Klinefelter syndrome: a challenge for endocrinologists 
Münster, Germany
Sun 20 16:15
S9.3
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Does "healthy obesity" exist in andrology? 
Sun 20 17:15
PL3
Plenary 3 - The wonder world of GnRH neurons - cracking the pulse generator
The wonder world of GnRH neurons - cracking the pulse generator
Cambridge, UK
Mon 21
MTE9
Meet The Expert 9 - Premature ovarian failure: an endocrine perspective
Premature ovarian failure: an endocrine perspective
Mon 21
EHM1
European Hormone Medal Lecture - Unraveling secrets of the hypothalami-pituitary-gonadal axis
Unraveling secrets of the hypothalamic-pituitary-gonadal axis
London, UK
Mon 21 10:15
S14.1
Symposium 14: Neuroendocrine basis of reproductive disorders
Developmental wiring of GnRH neurons
Mon 21 10:45
S14.2
Symposium 14: Neuroendocrine basis of reproductive disorders
Neuroendocrinology right from the nose: genetics and pathophysiology of the olfacto-genital syndrome (Kallmann syndrome)
Mon 21 11:15
S14.3
Symposium 14: Neuroendocrine basis of reproductive disorders
Metabolic-reproductive interactions: From bench to bedside
Mon 21 12:15
D4.1
Debate 4: AMH as the Primary Marker for Fertility
FOR - AMH as the Primary Marker for Fertility
Mon 21 12:15
D4.2
Debate 4: AMH as the Primary Marker for Fertility
AGAINST - AMH as the Primary Marker for Fertility
Mon 21 15:15
S18.1
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Sex hormones, obesity and type 2 diabetes – is there a link?
Mon 21 15:45
S18.2
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Relevant therapies in PCOS
Mon 21 16:15
S18.3
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Testosterone, obesity and the metabolic syndrome in males – do we need to replace steroids?
Tue 22
MTE13
Meet The Expert 13 - Erectile Dysfunction
Erectile Dysfunction
Tue 22 09:45
S21.1
Symposium 21: The Dance of Adrenal and Gonads
The interplay Between the Ovaries and Adrenals
Tue 22 10:15
S21.2
Symposium 21: The Dance of Adrenal and Gonads
Management of phaeochromocytoma during pregnancy
London, UK
Tue 22 10:45
S21.3
Symposium 21: The Dance of Adrenal and Gonads
Fertility in Congenital Adrenal Hyperplasia
Sun 20 08:00
MTBS1
Meet The Expert - Basic Scientist 1: Mouse models in endocrine tumors
Mouse models in endocrine tumors
Sun 20
D1.1
Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
For - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Sun 20
D1.2
Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Against - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Sun 20 15:15
S10.1
Symposium 10: Hot topics in NETs
Whole Genome Landscape in pancreatic neuroendocrine tumours
Sun 20 15:45
S10.2
Symposium 10: Hot topics in NETs
Treatment of small intestine and pancreatic NETs what and when?
Sun 20 16:15
S10.3
Symposium 10: Hot topics in NETs
Treatment update on carcinoid syndrome and carcinoid heart disease
Sun 20 15:15
GL1.1
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Introduction to ENSAT Guidelines
Sun 20 15:20
GL1.2
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Methods
Sun 20 15:30
GL1.3
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Pathology & Prognostic factors
Sun 20 15:45
GL1.4
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Adjuvant therapy
Sun 20 16:00
GL1.5
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Therapy of advanced ACC
Sun 20 16:15
GL1.6
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Special considerations on mitotane
Mon 21
NSA3
New Scientific Approach 3 - Re-Programming Strategies to Obtain Functional Endocrine Units
Re-Programming Strategies to Obtain Functional Endocrine Units
Mon 21 15:15
S17.1
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Adrenal development and benign tumor formation
Mon 21 15:45
S17.2
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Genetics of Primary Adrenal Macronodular Hyperplasia: when and what to test
Mon 21 16:15
S17.3
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Diagnosis and management of Primary Adrenal Macronodular Hyperplasia
Tue 22
MTE12
Meet The Expert 12 - Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
Tue 22
MTE16
Meet The Expert 16 - Adrenal incidentaloms
Adrenal incidentaloms
Sheffield, UK
Tue 22
NSA5
New Scientific Approach 5 - Circulating miRNAs in Endocrine Tumours
Circulating miRNAs in Endocrine Tumours
Sun 20 08:00
MTE2
Meet The Expert 2 - Acromegaly: Optimal management after surgery
Acromegaly: Optimal management after surgery
Sun 20 10:15
S2.1
Symposium 2: Salt and Sweet
Hyponatremia and mortality: moving beyond associations
Sun 20 10:45
S2.2
Symposium 2: Salt and Sweet
Hereditary Diabetes insipidus
Sun 20 11:15
S2.3
Symposium 2: Salt and Sweet
Sweet preference induced by FGF21
Sun 20 14:00
NSA2
New Scientific Approach 2 - The spliceosome as a target treatment of endocrine tumours
The spliceosome as a target treatment of endocrine tumours
Sun 20
D2.1
Debate 2 - Receptor profiling is useful for predicting pituitary therapy
For - Receptor profiling is useful for predicting pituitary therapy
Sun 20
D2.2
Debate 2 - Receptor profiling is useful for predicting pituitary therapy
Against - Receptor profiling is useful for predicting pituitary therapy
Mon 21
MTE8
Meet The Expert 8 - Hormone replacement for the travelling patient
Hormone replacement for the travelling patient
Mon 21
MTEBS2
Meet the Expert - Basic Scientist 2 -Single-cell sequencing in endocrine diseases
Single-cell sequencing in endocrine diseases
London, UK
Mon 21 10:15
S11.1
Symposium 11: Novel aspects of Craniopharyngioma
Molecular Pathogenensis of Craniopharyngioma
London, UK
Mon 21 10:45
S11.2
Symposium 11: Novel aspects of Craniopharyngioma
Bariatric Surgery as Treatment in Craniopharyngioma
Mon 21 11:15
S11.3
Symposium 11: Novel aspects of Craniopharyngioma
Psychosocial dysfunction after treatment of of Craniopharyngioma
Mon 21
NSA4
New Scientific Approach 4 - 3D visualisation of the HPG axis in mice and humans
3D visualisation of the HPG axis in mice and humans
Milan, Italy
Mon 21 15:15
S19.1
Symposium 19: New Aspects of Pituitary Regulation
Cytoskeleton and pharmacologic resistance in pituitary tumours
Mon 21 15:45
S19.2
Symposium 19: New Aspects of Pituitary Regulation
What fat does with your pituitary
Mon 21 16:15
S19.3
Symposium 19: New Aspects of Pituitary Regulation
How cancer treatment effects your pituitary
Mon 21 17:15
CET1
Clinical Endocrinology Trust Lecture - Growth Hormone: not too much...not too less!
Growth Hormone: not too much...not to less!
Paris, France
Tue 22
MTE15
Meet The Expert 15 - Your emergency consult about hyponatraemia
Your emergency consult about hyponatraemia
Tue 22 09:45
S24.1
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
How Does Pituitary Release its Hormones?
Montpellier, France
Tue 22 10:15
S24.2
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
Peripheral Activities of Growth Hormone-Releasing Hormone (GHRH)
Tue 22 10:45
S24.3
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
How Do Hypopituitary Patients Deal with Stress?
Tue 22 14:45
S26.1
Symposium 26: Cortisol: Too much of a Good Thing
Genetics of Cushing's disease
Tue 22 15:15
S26.2
Symposium 26: Cortisol: Too much of a Good Thing
Hypercortisolism and the Brain
Tue 22 15:45
S26.3
Symposium 26: Cortisol: Too much of a Good Thing
Differentiating Cushing from Pseudo-Cushing
Sun 20 08:00
MTE4
Meet The Expert 4 - Osteoporosis in men
Osteoporosis in men
Sun 20 09:15
PL2
Plenary 2 - Bone regulates the Brain
Bone regulates the Brain
Sun 20 10:15
SS1.1
Special Symposium: Bone & Vitamin D
Free and bound vitamin D and health outcomes.
Sun 20 10:45
SS1.2
Special Symposium: Bone & Vitamin D
Vitamin D and Critical Care
Sun 20 11:15
SS1.3
Special Symposium: Bone & Vitamin D
Vitamin D, macrophages and atherosclerosis
Sun 20 15:15
S8.1
Symposium 8: Bone fragility – from bench to clinic
Clinical spectrum of new monogenic forms of osteoporosis
Helsinki, Finland
Sun 20 15:45
S8.2
Symposium 8: Bone fragility – from bench to clinic
What have we learnt from genome-wide association studies in osteoporosis
Sun 20 16:15
S8.3
Symposium 8: Bone fragility – from bench to clinic
Hypophosphatasia
Mon 21
MTE10
Meet The Expert 10 - Effects of gender-affirming hormone therapy on bone in transgender persons
Effects of gender-affirming hormone therapy on bone in transgender persons
Mon 21 10:15
S12.1
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Increased fracture rate in diabetes and obesity      
Mon 21 10:45
S12.2
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Bone quality evaluation in Pituitary diseases
Mon 21 11:15
S12.3
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Effect of parathyroid dysfunction on incidence of bone fractures
Tue 22
MTE14
Meet The Expert 14 - Vitamin D for everybody
Vitamin D for everybody?
Tue 22 09:45
S22.1
Symposium 22: The fatty bone
Marrow adipose tissue and skeletal health
Tue 22 10:15
S22.2
Symposium 22: The fatty bone
Bone marrow adipose tissue: starving for attention?
Edinburgh , Scotland
Tue 22 10:45
S22.3
Symposium 22: The fatty bone
Cross-talk between bone marrow and periperal adipose tissue in man
Tue 22 14:45
S27.1
Symposium 27: Emerging treatments in osteoporosis
Molecular basis of bone anabolism
Tue 22 15:15
S27.2
Symposium 27: Emerging treatments in osteoporosis
Novel therapies: PTH-related protein and sclerostin inhibition
Tue 22 15:45
S27.3
Symposium 27: Emerging treatments in osteoporosis
Sequential and combination therapy for osteoporosis
Sun 20 08:00
MTE5
Meet The Expert 5 - Medullary thyroid cancer beyond surgery
Medullary thyroid cancer beyond surgery
Sun 20 10:15
S1.1
Symposium 1: Predicting events in autoimmune thyroid disease
The THEA score in familial thyroid dysfunction
Sun 20 10:45
S1.2
Symposium 1: Predicting events in autoimmune thyroid disease
IgG4 related thyroid autoimmune disease
Sun 20 11:15
S1.3
Symposium 1: Predicting events in autoimmune thyroid disease
New scores for the prediction of Graves' disease
Sun 20 15:15
S7.1
Symposium 7: Expanding the spectrum of thyroid hormone use
TRIAC Trial in Allan-Herndon-Dudley-Syndrome (MCT8)
Sun 20 15:45
S7.2
Symposium 7: Expanding the spectrum of thyroid hormone use
Tetrac as an antiangiogenic agent in cancer
Sun 20 16:15
S7.3
Symposium 7: Expanding the spectrum of thyroid hormone use
New applications of thyroid hormones, analogs, and metabolites in non-alcoholic fatty liver
Mon 21
MTE7
Meet The Expert 7 - Difficult cases of differentiated thyroid cancer
Difficult cases of differentiated thyroid cancer
Mon 21
D3.1
Debate 3: Subclinical hypothyroidism is a disease
FOR - Subclinical hypothyroidism is a disease
Mon 21
D3.2
Debate 3: Subclinical hypothyroidism is a disease
AGAINST - Subclinical hypothyroidism is a disease
Mon 21 15:15
S16.1
Symposium 16: Changing practice in the management of thyroid neoplasms
Genomic alterations in thyroid malignancies
Mon 21 15:45
S16.2
Symposium 16: Changing practice in the management of thyroid neoplasms
Composite approach in the evaluation and management of thyroid nodule
Mon 21 16:15
S16.3
Symposium 16: Changing practice in the management of thyroid neoplasms
New classification and guidelines in differentiated thryroid cancers
Tue 22
MTBS3
Meet The Expert - Basic Scientist 3: Watch out for noncanonical mechanisms of thyroid hormone action!
Watch out for noncanonical mechanisms of thyroid hormone action!
Essen, Germany
Tue 22
PL6
Plenary 6: Does therapy for thyroid dysfunction decrease mortality?
Does therapy for thyroid dysfunction decrease mortality?
Tue 22
D5.1
Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
FOR - Pregnant women should be screened for thyroid hormones and antibodies
Birmingham, UK
Tue 22
D5.2
Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
AGAINST - Pregnant women should be screened for thyroid hormones and antibodies
Tue 22
NSA6
New Scientific Approach 6 - Functional thyroid in the dish
Functional thyroid in the dish
Brussels, Belgium
Tue 22 14:45
S29.1
Symposium 29: Thyroid hormone action: regulation and clinical implications
Tissue-specific regulation of thyroid hormone action
Tue 22 15:15
S29.2
Symposium 29: Thyroid hormone action: regulation and clinical implications
Thyroid hormone economy in human aging
Leiden, The Netherlands
Tue 22 15:45
S29.3
Symposium 29: Thyroid hormone action: regulation and clinical implications
Elevated TSH in Children
Copenhagen, Denmark
Sun 20 10:15
S4.1
Symposium 4: Environmental Effects on Endocrine Function
Developmental Reprogramming of the Epigenome by Endocrine Disrupting Chemicals that Increase Cancer Risk
Sun 20 10:45
S4.2
Symposium 4: Environmental Effects on Endocrine Function
Iodine deficiency in pregnancy and development of offspring
Sun 20 11:15
S4.3
Symposium 4: Environmental Effects on Endocrine Function
Environmental contaminants and endocrine disruption: The story of obesogens
Tue 22 09:45
Endo-ERN: concrete examples of added value for patient care
Introduction, structure, and virtual consultation using the EU-ERN CPMS
Amsterdam, The Netherlands
Tue 22 10:00
Endo-ERN: concrete examples of added value for patient care
Caring for endocrinology across the life span: DSD and Hypogonadotropic hypogonadism
Lübeck, Germany
Tue 22 10:15
Endo-ERN: concrete examples of added value for patient care
Patient and family perspectives
Tue 22
D6.1
Debate 6: Endocrine disruptors: Regulatory vs. Scientific Perspectives
SCIENCE - Endocrine disruptors: Regulatory vs. Scientific Perspectives
Tue 22
D6.2
Debate 6: Endocrine disruptors: Regulatory vs. Scientific Perspectives
REGULATORY - Endocrine disruptors: Regulatory vs. Scientific Perspectives
Sun 20 10:15
N1.1
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Good- Overview and Indications of Immunotherapy in Oncology
Sun 20 10:45
N1.2
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Bad - Immunotherapy-induced Endocrinopathy
Birmingham, UK
Sun 20 11:15
N1.3
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Witty - The Role of Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathy
Birmingham , United Kingdom
Sun 20 12:00
N2.1
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Key Note Speaker: Principles and models of Transition – an overview
Sun 20 12:30
N2.2
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Paediatric to adult transition in Endocrinology
Sun 20 12:35
N2.3
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Transition between settings: hospital to community
Sun 20 12:40
N2.4
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Transition in Hypogonadism
London, UK
Mon 21 10:15
S15.1
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Introduction to EYES
Mon 21 10:20
S15.2
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Metabolic reprogramming of cancer cells
Mon 21 10:40
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Epigenetic and metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas
Mon 21 11:00
S15.4
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Immune Checkpoint Inhibitor Induced Hypophysitis – Experiences from the United Kingdom
Birmingham, UK
Mon 21 11:20
S15.5
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Alterations in Clock genes expression in human benign adrenal tumors
Mon 21 11:40
S15.6
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Invitation to EYES networking and annual meeting
Mon 21 12:00
N3.1
Meet the Nurse Expert & Case Discussions
Nursing Management of CAH: Education & Use of Multi-media Technology
Mon 21 15:15
N4.1
Nurses professional development, networking session and oral/poster presentations
Welcome and update on ESE nurse activties
London, UK
Mon 21 15:30
N4.2
Nurses professional development, networking session and oral/poster presentations
Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance test with two different doses
London, UK
Mon 21 15:45
N4.3
Nurses professional development, networking session and oral/poster presentations
Role of the Endocrine nurse in the MDT in improving care for patients with thyroid cancer
Mon 21 16:00
N4.4
Nurses professional development, networking session and oral/poster presentations
Influence of educational training course in improving knowledge of diabetes mellitus among nurses
Mon 21 16:45
N4.5
Nurses professional development, networking session and oral/poster presentations
Poster awards presentation, workshops & networking session
Tue 22 09:45
S25.1
Symposium 25: Late breaking
Microvesicles and exosomes: new players in metabolic diseases
Tue 22 10:15
S25.2
Symposium 25: Late breaking
Senescence-associated reprogramming promotes cancer stemness
Tue 22 10:45
S25.3
Symposium 25: Late breaking
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Tue 22 14:45
S28.1
Symposium 28: Endocrinology Meets Immunology
Concept of Immunotherapy in Cancer
Tue 22 15:15
S28.2
Symposium 28: Endocrinology Meets Immunology
Immunotherapy for Thyroid Carcinoma
Tue 22 15:45
S28.3
Symposium 28: Endocrinology Meets Immunology
Immunotherapy Related Endocrinopathies
Tue 22 14:45
S30.1
Symposium 30: Disorders of Sexual Development (DSD)
Long term consequences of Disorders of Sexual Development
Tue 22 15:15
S30.2
Symposium 30: Disorders of Sexual Development (DSD)
Atypical Genital Development and Hypospadias: a Pediatric Urology perspective from Etiology to Surgery
Tue 22 15:45
S30.3
Symposium 30: Disorders of Sexual Development (DSD)
Gender Dysphoria and Brain Function
Belgium
Tue 22 17:15
PL7
Plenary 7: Metabolic control of longevity
Metabolic control of longevity
Tue 22 14:45
Career Development - Presentation Skills Workshop
Roy is a professional speaker who will share priceless and unexpected tips and techniques that the professionals use so that you can transform your presentations
Chair: Roy Sheppard (UK)
Sun 20 12:00
OC1.1
Oral Communication: Benign thyroid diseases
Familial gestational hyperthyroidism caused by Val597Ile mutant of TSH receptor gene with human chorionic gonadotropin hypersensitivity
Sun 20 12:12
OC1.2
Oral Communication: Benign thyroid diseases
Relationship between TSH values in the first trimester of pregnancy and obstetric and neonatal complications
Sun 20 12:24
OC1.3
Oral Communication: Benign thyroid diseases
Thyroid hormone replacement therapy for subclinical hypothyroidism in adults: systematic review and meta-analysis of randomized-controlled trials
Sun 20 12:36
OC1.4
Oral Communication: Benign thyroid diseases
The Impact of Obligatory Iodine Prophylaxis on Thyroid Volume in Schoolchildren
Sun 20 12:48
OC1.5
Oral Communication: Benign thyroid diseases
Low free T3 levels within the reference range independently predict cardiovascular mortality in the general population
Sun 20 12:00
OC2.1
Oral Communication: Look who is controlling your gonads!
The in vivo and in vitro effects of kisspeptin on human ovarian function
Sun 20 12:12
OC2.2
Oral Communication: Look who is controlling your gonads!
Overexpressed kisspeptin/Kiss1R system in human granulosa cells may be involved in the pathogenesis of polycystic ovary syndrome (PCOS) by inhibiting ovulation.
Sun 20 12:24
OC2.3
Oral Communication: Look who is controlling your gonads!
Whole exome sequencing in non-obstructive azoospermia allows the identification of a high-risk subgroup of infertile men for undiagnosed Fanconi Anemia, a cancer-prone disease.
Sun 20 12:36
OC2.4
Oral Communication: Look who is controlling your gonads!
Novel Role of Central Ceramide Signaling in Mediating Obesity-Induced Precocious Puberty
Sun 20 12:48
OC2.5
Oral Communication: Look who is controlling your gonads!
Effect of thyroxine replacement on leydig cell and sertoli cell function in men with hypothyroidism
Sun 20 12:00
OC3.1
Oral Communication: New insights in bone disorders
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Burosumab, an Anti-FGF23 Antibody, In Adult X-Linked Hypophosphatemia (XLH)
Sun 20 12:12
OC3.2
Oral Communication: New insights in bone disorders
Can a bone protein protect against muscular dystrophy?
Sun 20 12:24
OC3.3
Oral Communication: New insights in bone disorders
[18F]-FDG PET/CT imaging: A tool to reveal the metabolic functions of bone marrow adipose tissue
Edinburgh, UK
Sun 20 12:36
OC3.4
Oral Communication: New insights in bone disorders
Renal function change in chronic hypoparathyroidism patients treated with recombinant human parathyroid hormone (1-84) (rhPTH[1-84]) and in a historical control cohort treated with standard therapy
Sun 20 12:48
OC3.5
Oral Communication: New insights in bone disorders
Change in bone mineral density during the first 10 years of gender affirming hormonal treatment in transwomen and transmen
Amsterdam, The Netherlands
Sun 20 12:00
OC4.1
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Dietary intervention modulates the expression of the splicing machinery in patients at high-risk of type 2 diabetes development: clinical implications
Sun 20 12:12
OC4.2
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Toe brachial index predicts major adverse cardiovascular events in patients with type 2 diabetes
Sun 20 12:24
OC4.3
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Effects of TRAIL delivery on an experimental model of type 2 diabetes and diabetic nephropathy
Sun 20 12:36
OC4.4
Oral Communication: Novel insights into prediabetes and type 2 diabetes
Association between prediabetes and incidence of chronic kidney disease, incident albuminuria, or worsening of kidney function: a secondary analysis of the SPRINT trial
Sun 20 12:48
OC4.5
Oral Communication: Novel insights into prediabetes and type 2 diabetes
The impact of prediabetes in lung function: data from the ILERVAS project
Mon 21 12:00
OC5.1
Oral Communication: Diving deep into adrenal cortex diseases
Is adrenal computed tomography accurate for the diagnosis of unilateral primary aldosteronism? A retrospective international cohort study
Mon 21 12:12
OC5.2
Oral Communication: Diving deep into adrenal cortex diseases
Steroid profiling by liquid chromatography tandem mass spectrometry in a large cohort of patients with adrenal incidentalomas
Mon 21 12:24
OC5.3
Oral Communication: Diving deep into adrenal cortex diseases
PRKACA L206R mutation in adrenal Cushing’s syndrome makes PKA RIIβ susceptible for caspase-mediated cleavage
Mon 21 12:36
OC5.4
Oral Communication: Diving deep into adrenal cortex diseases
Assessment of Tissue Sodium Content by 23Na-MRI in Patients with Adrenal Insufficiency – a Pilot Study
Mon 21 12:48
OC5.5
Oral Communication: Diving deep into adrenal cortex diseases
Cullin 3 is a partner of Armadillo Repeat Containing 5 (ARMC5), the product of the gene responsible for Primary Bilateral Macronodular Adrenal Hyperplasia
Mon 21 12:00
OC6.1
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
5β-reductase (AKR1D1) is a potent regulator of hepatic insulin sensitivity, carbohydrate and lipid metabolism in vitro and in vivo
Oxford, United Kingdom
Mon 21 12:12
OC6.2
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
DEEP TRANSCRANIAL MAGNETIC STIMULATION ACUTELY MODULATES NEURO-ENDOCRINE PATHWAYS UNDERLYING OBESITY
Mon 21 12:24
OC6.3
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Visceral fat assessment in lamin A/C mutation carriers: Phenotype-Genotype correlation
Mon 21 12:36
OC6.4
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Anthropometric measurements and metabolic syndrome in relation to glucocorticoid receptor polymorphisms in (local) corticosteroid users
Mon 21 12:48
OC6.5
Oral Communication: Genetic and environmental determinants of obesity and insulin resistance
Associations of different body fat deposits with serum 25-hydroxyvitamin D concentrations
Mon 21 12:00
OC7.1
Oral Communication: Genomic and clinical aspects of endocrine tumours
Molecular classification of benign adrenocortical tumors: an integrated genomic study
Mon 21 12:12
OC7.2
Oral Communication: Genomic and clinical aspects of endocrine tumours
Urine steroid metabolomics as a diagnostic tool for detection of adrenocortical malignancy – a prospective test validation study
Mon 21 12:24
OC7.3
Oral Communication: Genomic and clinical aspects of endocrine tumours
IncRNAs profiling reveals epigenetic heterogeneity among human parathyroid tumor
Mon 21 12:36
OC7.4
Oral Communication: Genomic and clinical aspects of endocrine tumours
Germline mutations in the mitochondrial 2-oxoglutarate/malate carrier (SLC25A11) gene confer predisposition to metastatic paragangliomas.
Mon 21 12:48
OC7.5
Oral Communication: Genomic and clinical aspects of endocrine tumours
Randomized trial comparing phenoxybenzamine and doxazosine for preoperative treatment of patients with a pheochromocytoma (PRESCRIPT)
Mon 21 12:00
OC8.1
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Plasma microRNA expression in patients with Cushing’s disease differs from ACTH-ectopic Cushing’s syndrome.
Mon 21 12:12
OC8.2
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
MicroRNA expression profiling and functional annotation analysis of their targets in patients with diabetic kidney disease.
Mon 21 12:24
OC8.3
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Circulating Levels of microRNAs Associate with Blood Pressure and Left Ventricular Mass in Primary Hypertensive Patients
Mon 21 12:36
OC8.4
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
Detecting blood micro-RNAs and proteins associated with Graves’ disease and orbitopathy
Mon 21 12:48
OC8.5
Oral Communication: MicroRNAs as biomarkers in endocrine diseases
MicroRNA profiles in diabetic octogenarians with and without historical and prospective hip fractures
Mon 21 12:00
OC9.1
Oral Communication: Thyroid from basics to clinics
Increased urinary iodine precedes hypothyroidism in Dehal1 knockout mice
Mon 21 12:12
OC9.2
Oral Communication: Thyroid from basics to clinics
Anti-tumoral effects of metformin on metastatic bone lesions of thyroid cancer
Korea, Republic of
Mon 21 12:24
OC9.3
Oral Communication: Thyroid from basics to clinics
A mouse model of BRAF V600E mutated papillary thyroid cancer imitating sporadic conditions
Mon 21 12:36
OC9.4
Oral Communication: Thyroid from basics to clinics
Identification of an epigenetic biomarker panel for predicting the development of distant metastases in differentiated thyroid cancer
Tue 22 11:30
OC10.1
Oral Communication: Cardiovascular aspects of endocrine diseases
Glucocorticoid replacement-doses and cardiovascular events in autoimmune Addison’s disease – a population based retrospective cohort study.
Tue 22 11:42
OC10.2
Oral Communication: Cardiovascular aspects of endocrine diseases
Canagliflozin attenuates the progression of atherosclerosis via reducing hyperlipidaemia and inflammation process in ApoE KO Mice
Tue 22 11:54
OC10.3
Oral Communication: Cardiovascular aspects of endocrine diseases
ARMC5 variants and risk of hypertension in African Americans: Minority Health-GRID study
Tue 22 12:06
OC10.4
Oral Communication: Cardiovascular aspects of endocrine diseases
Improvement in the control of hypertension in diabetic patients screened for hyperaldosteronism
Tue 22 12:18
OC10.5
Oral Communication: Cardiovascular aspects of endocrine diseases
Increased Risk of Antithyroid Drug-induced Agranulocytosis with Amiodarone
Tue 22 11:30
OC11.1
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Targeted molecular analysis in adrenocortical carcinomas: a way towards improved personalized prognostication.​
Birmingham, United Kingdom
Tue 22 11:42
OC11.2
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma
Tue 22 11:54
OC11.3
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Clinical and histopathological differences between MEN1 carriers and MEN1 phenocopy patients
Tue 22 12:06
OC11.4
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Update in the genetic landscape of Cushing’s Disease: TP53 and a new deubiquitinase in spotlight
Tue 22 12:18
OC11.5
Oral Communication: Clinical practice in endocrine tumours: combining conventional and molecular features
Natural history of Rathke’s Cleft Cysts: a multicenter experience
Tue 22 11:30
OC12.1
Oral Communication: Novel aspects of puberty development and Cushing's disease
Growth hormone signaling in leptin receptor expressing cells, but not in Kiss1 expressing neurons, regulates the timing of puberty
Tue 22 11:42
OC12.2
Oral Communication: Novel aspects of puberty development and Cushing's disease
Oligogenicity in Kallmann syndrome - an underestimated phenomenon?
Tue 22 11:54
OC12.3
Oral Communication: Novel aspects of puberty development and Cushing's disease
Evaluation of genetic predisposition in severe and mild phenotypes of isolated hypogonadotropic hypogonadism
Tue 22 12:06
OC12.4
Oral Communication: Novel aspects of puberty development and Cushing's disease
Late-night salivary cortisol (LNSC) levels in a Phase III study of long-­acting pasireotide in patients with Cushing’s disease (CD)
Tue 22 12:18
OC12.5
Oral Communication: Novel aspects of puberty development and Cushing's disease
Diabetes mellitus and muscle weakness are independently associated with mortality in patients with Cushing's syndrome. Data from ERCUSYN.
Tue 22 11:30
OC13.1
Oral Communication: The curious case of growth hormone
Postoperative use of somatostatin analogs and mortality in patients with acromegaly.
Tue 22 11:42
OC13.2
Oral Communication: The curious case of growth hormone
Time trends of mortality in patients with GH secreting and non-functioning pituitary adenoma.
Tue 22 11:54
OC13.3
Oral Communication: The curious case of growth hormone
Molecular profiling for assistance to pharmacological treatment of acromegaly
Tue 22 12:06
OC13.4
Oral Communication: The curious case of growth hormone
Effects of Pegvisomant on Glucose Metabolism in Acromegaly: A Meta-analysis of Prospective Interventional Studies
Tue 22 12:18
OC13.5
Oral Communication: The curious case of growth hormone
Growth hormone acts in AGRP neurons to control energy expenditure during food restriction and promotes counter-regulatory responses to hypoglycemia via the ventromedial hypothalamus
Tue 22 11:42
OC14.2
Oral Communication: What is new in gestational and type 1 diabetes?
Profiling of activation patterns of placental mTOR in pregnancies complicated by gestational diabetes mellitus
Tue 22 11:54
OC14.3
Oral Communication: What is new in gestational and type 1 diabetes?
Patrolling monocytes are activated in diabetes and provide protection to retinal vessels in the context of leukostasis.
Tue 22 12:06
OC14.4
Oral Communication: What is new in gestational and type 1 diabetes?
The variability of glycemia and the metabolic composition of brain cells in patients with type 1 diabetes mellitus
Tue 22 12:18
OC14.5
Oral Communication: What is new in gestational and type 1 diabetes?
Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine
Sun 20 08:00
MTBS1
Meet The Expert - Basic Scientist 1: Mouse models in endocrine tumors
Mouse models in endocrine tumors
Sun 20 08:00
MTE1
Meet The Expert 1 - Using diabetes technologies to improve pateint self care
Using diabetes technologies to improve pateint self care
Sun 20 08:00
MTE2
Meet The Expert 2 - Acromegaly: Optimal management after surgery
Acromegaly: Optimal management after surgery
Sun 20 08:00
MTE3
Meet The Expert 3 - Managing delayed puberty
Managing delayed puberty
Helsinki, Finland
Sun 20 08:00
MTE4
Meet The Expert 4 - Osteoporosis in men
Osteoporosis in men
Sun 20 08:00
MTE5
Meet The Expert 5 - Medullary thyroid cancer beyond surgery
Medullary thyroid cancer beyond surgery
Mon 21
MTE6
Meet The Expert 6 - Long term implications of hypoglycaemia in diabetes
Long term implications of hypoglycaemia in diabetes
Mon 21
MTE7
Meet The Expert 7 - Difficult cases of differentiated thyroid cancer
Difficult cases of differentiated thyroid cancer
Mon 21
MTE8
Meet The Expert 8 - Hormone replacement for the travelling patient
Hormone replacement for the travelling patient
Mon 21
MTE9
Meet The Expert 9 - Premature ovarian failure: an endocrine perspective
Premature ovarian failure: an endocrine perspective
Mon 21
MTE10
Meet The Expert 10 - Effects of gender-affirming hormone therapy on bone in transgender persons
Effects of gender-affirming hormone therapy on bone in transgender persons
Mon 21
MTEBS2
Meet the Expert - Basic Scientist 2 -Single-cell sequencing in endocrine diseases
Single-cell sequencing in endocrine diseases
London, UK
Tue 22
MTE11
Meet The Expert 11 - How to integrate PCSk9 inhibitors into hyperlipademia management
How to integrate PCSk9 inhibitors into hyperlipademia management
Tue 22
MTE12
Meet The Expert 12 - Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
Controversies in NETs: Is high dose SSA treatment relevant and who needs hemicolectomy?
Tue 22
MTE13
Meet The Expert 13 - Erectile Dysfunction
Erectile Dysfunction
Tue 22
MTE14
Meet The Expert 14 - Vitamin D for everybody
Vitamin D for everybody?
Tue 22
MTE15
Meet The Expert 15 - Your emergency consult about hyponatraemia
Your emergency consult about hyponatraemia
Tue 22
MTE16
Meet The Expert 16 - Adrenal incidentaloms
Adrenal incidentaloms
Sheffield, UK
Tue 22
MTBS3
Meet The Expert - Basic Scientist 3: Watch out for noncanonical mechanisms of thyroid hormone action!
Watch out for noncanonical mechanisms of thyroid hormone action!
Essen, Germany
Tue 22
NSA5
New Scientific Approach 5 - Circulating miRNAs in Endocrine Tumours
Circulating miRNAs in Endocrine Tumours
Tue 22
NSA6
New Scientific Approach 6 - Functional thyroid in the dish
Functional thyroid in the dish
Brussels, Belgium
Sat 19 18:15
GH1
Geoffrey Harris Lecture - Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans
Sat 19 19:25
PL1
Plenary 1: Contraception: Past and future
Contraception: Past and future
Sun 20 09:15
PL2
Plenary 2 - Bone regulates the Brain
Bone regulates the Brain
Sun 20 17:15
PL3
Plenary 3 - The wonder world of GnRH neurons - cracking the pulse generator
The wonder world of GnRH neurons - cracking the pulse generator
Cambridge, UK
Mon 21
PL4
Plenary 4 - The Retina as a Window for Exploring the Brain in Diabetes
The Retina as a Window for Exploring the Brain in Diabetes
Mon 21
EHM1
European Hormone Medal Lecture - Unraveling secrets of the hypothalami-pituitary-gonadal axis
Unraveling secrets of the hypothalamic-pituitary-gonadal axis
London, UK
Mon 21 17:15
CET1
Clinical Endocrinology Trust Lecture - Growth Hormone: not too much...not too less!
Growth Hormone: not too much...not to less!
Paris, France
Mon 21
PL5
Plenary 5: The link between insulin and fatty liver
The link between insulin and fatty liver
Tue 22
PL6
Plenary 6: Does therapy for thyroid dysfunction decrease mortality?
Does therapy for thyroid dysfunction decrease mortality?
Tue 22 17:15
PL7
Plenary 7: Metabolic control of longevity
Metabolic control of longevity
Sun 20 09:45
Tea & Coffee
EXHIBITION AREA
Sun 20 13:00
Lunch and Poster Viewing
EXHIBITION AREA
Sun 20 16:45
Tea & Coffee
EXHIBITION AREA
Mon 21 09:45
Tea & Coffee
EXHIBITION AREA
Mon 21 13:00
Lunch and Poster Viewing
EXHIBITION AREA
Mon 21 16:45
Tea & Coffee
EXHIBITION AREA
Tue 22 09:15
Tea & Coffee
EXHIBITION AREA
Tue 22 12:30
Lunch and Poster Viewing
EXHIBITION AREA
Chair: Please note the exhibition will close to delegates at 14:30 hrs
Tue 22 16:15
Tea & Coffee
ENTRANCE HALL
Sun 20 10:15
N1.1
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Good- Overview and Indications of Immunotherapy in Oncology
Sun 20 10:45
N1.2
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Bad - Immunotherapy-induced Endocrinopathy
Birmingham, UK
Sun 20 11:15
N1.3
Nurses MDT symposium: Immunotherapy: The Good, The Bad and Witty
The Witty - The Role of Endocrine Nurse in Managing Patients with Immunotherapy-induced Endocrinopathy
Birmingham , United Kingdom
Sun 20 12:00
N2.1
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Key Note Speaker: Principles and models of Transition – an overview
Sun 20 12:30
N2.2
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Paediatric to adult transition in Endocrinology
Sun 20 12:35
N2.3
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Transition between settings: hospital to community
Sun 20 12:40
N2.4
Nurses symposium & panel discussion: Bridging the Gap: models of care transitioning endocrine patients for paediatric to adult-oriented care
Transition in Hypogonadism
London, UK
Mon 21 12:00
N3.1
Meet the Nurse Expert & Case Discussions
Nursing Management of CAH: Education & Use of Multi-media Technology
Mon 21 15:15
N4.1
Nurses professional development, networking session and oral/poster presentations
Welcome and update on ESE nurse activties
London, UK
Mon 21 15:30
N4.2
Nurses professional development, networking session and oral/poster presentations
Comparison of glucose, peak growth hormone & peak cortisol levels during insulin tolerance test with two different doses
London, UK
Mon 21 15:45
N4.3
Nurses professional development, networking session and oral/poster presentations
Role of the Endocrine nurse in the MDT in improving care for patients with thyroid cancer
Mon 21 16:00
N4.4
Nurses professional development, networking session and oral/poster presentations
Influence of educational training course in improving knowledge of diabetes mellitus among nurses
Mon 21 16:45
N4.5
Nurses professional development, networking session and oral/poster presentations
Poster awards presentation, workshops & networking session
Sat 19 17:30
ECE 2018 Opening Ceremony
AUDITORIUM
Sat 19 18:50
EJE1
EJE Prize Lecture - A gut feeling about glucagon
A gut feeling about glucagon
Sun 20
UEM1.1
UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
News from Brussels
Sun 20
UEM1.2
UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
ESE/UEMS European Board Examination in Endocrinology, Diabetes and Metabolism
Waterford, Ireland
Sun 20
UEM1.3
UEMS session - Session of the European Union of Medical Specialists Section of Endocrinology
UEMS 3E Grant Presentation: Endocrine disruptors and thyroid function during pregnancy
Netherlands, Netherlands
Sun 20
D1.1
Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
For - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Sun 20
D1.2
Debate 1 - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Against - Adrenal venous sampling vs. imaging for primary aldosteronism: beware of the caveats!
Sun 20
NSA1
New Scientific Approach 1 - New tools for investigating insulin secretion
New tools for investigating insulin secretion
Sun 20 14:00
NSA2
New Scientific Approach 2 - The spliceosome as a target treatment of endocrine tumours
The spliceosome as a target treatment of endocrine tumours
Mon 21
D3.1
Debate 3: Subclinical hypothyroidism is a disease
FOR - Subclinical hypothyroidism is a disease
Mon 21
D3.2
Debate 3: Subclinical hypothyroidism is a disease
AGAINST - Subclinical hypothyroidism is a disease
Mon 21 12:15
D4.1
Debate 4: AMH as the Primary Marker for Fertility
FOR - AMH as the Primary Marker for Fertility
Mon 21 12:15
D4.2
Debate 4: AMH as the Primary Marker for Fertility
AGAINST - AMH as the Primary Marker for Fertility
Mon 21 13:00
ESE President meets new members
Mon 21
NSA3
New Scientific Approach 3 - Re-Programming Strategies to Obtain Functional Endocrine Units
Re-Programming Strategies to Obtain Functional Endocrine Units
Mon 21
NSA4
New Scientific Approach 4 - 3D visualisation of the HPG axis in mice and humans
3D visualisation of the HPG axis in mice and humans
Milan, Italy
Mon 21
PW1.1
Publishing Workshop
Introduction from the Chair
Mon 21
PW1.2
Publishing Workshop
Responding to reviewer comments
Mon 21
PW1.3
Publishing Workshop
How to select your journal and submit your paper
Mon 21
PW1.4
Publishing Workshop
Publishing ethics
Melbourne, Australia
Mon 21
PW1.5
Publishing Workshop
Data presentation, precision and ‘pseudoprecision’
Mon 21
Publishing Workshop
Questions and discussion
Tue 22
D5.1
Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
FOR - Pregnant women should be screened for thyroid hormones and antibodies
Birmingham, UK
Tue 22
D5.2
Debate 5: Pregnant women should be screened for thyroid hormones and antibodies
AGAINST - Pregnant women should be screened for thyroid hormones and antibodies
Tue 22
D6.1
Debate 6: Endocrine disruptors: Regulatory vs. Scientific Perspectives
SCIENCE - Endocrine disruptors: Regulatory vs. Scientific Perspectives
Tue 22
D6.2
Debate 6: Endocrine disruptors: Regulatory vs. Scientific Perspectives
REGULATORY - Endocrine disruptors: Regulatory vs. Scientific Perspectives
Tue 22 11:30
ESE Council of Affiliated Societies Session
Room 111
Tue 22 12:45
ESE Annual General Meeting
All ESE members are welcome to attend
Room 111
Tue 22 16:45
ESE Awards Presentation
AUDITORIUM
Tue 22 17:45
Closing Ceremony
AUDITORIUM
Sat 19 15:30
Satellite Symposium
Sun 20 10:15
S1.1
Symposium 1: Predicting events in autoimmune thyroid disease
The THEA score in familial thyroid dysfunction
Sun 20 10:45
S1.2
Symposium 1: Predicting events in autoimmune thyroid disease
IgG4 related thyroid autoimmune disease
Sun 20 11:15
S1.3
Symposium 1: Predicting events in autoimmune thyroid disease
New scores for the prediction of Graves' disease
Sun 20 10:15
S2.1
Symposium 2: Salt and Sweet
Hyponatremia and mortality: moving beyond associations
Sun 20 10:45
S2.2
Symposium 2: Salt and Sweet
Hereditary Diabetes insipidus
Sun 20 11:15
S2.3
Symposium 2: Salt and Sweet
Sweet preference induced by FGF21
Sun 20 10:15
S3.1
Symposium 3: Bile Acid and Microbiota
Crosstalk between bile acids and intestinal microbiota - influence on host metabolism
Sun 20 10:45
S3.2
Symposium 3: Bile Acid and Microbiota
5β-reductase, bile acid synthesis, and the control of energy metabolism
Sun 20 11:15
S3.3
Symposium 3: Bile Acid and Microbiota
Bile acids and metabolic effects of bariatric surgery
Sun 20 10:15
S4.1
Symposium 4: Environmental Effects on Endocrine Function
Developmental Reprogramming of the Epigenome by Endocrine Disrupting Chemicals that Increase Cancer Risk
Sun 20 10:45
S4.2
Symposium 4: Environmental Effects on Endocrine Function
Iodine deficiency in pregnancy and development of offspring
Sun 20 11:15
S4.3
Symposium 4: Environmental Effects on Endocrine Function
Environmental contaminants and endocrine disruption: The story of obesogens
Sun 20 10:15
S5.1
Symposium 5: The role of sperm epigenome in fertility and inheritance
The quality control of the male germline transcriptome
Sun 20 10:45
S5.2
Symposium 5: The role of sperm epigenome in fertility and inheritance
Epigenetic germline mosaicism in infertile men
Sun 20 11:15
S5.3
Symposium 5: The role of sperm epigenome in fertility and inheritance
Mechanisms of epigenetic inheritance through sperm: lessons we have learnt from model organisms
Sun 20 10:15
SS1.1
Special Symposium: Bone & Vitamin D
Free and bound vitamin D and health outcomes.
Sun 20 10:45
SS1.2
Special Symposium: Bone & Vitamin D
Vitamin D and Critical Care
Sun 20 11:15
SS1.3
Special Symposium: Bone & Vitamin D
Vitamin D, macrophages and atherosclerosis
Sun 20 14:00
Satellite symposium
Sun 20 14:00
Satellite symposium
Sun 20 14:00
Satellite symposium
Sun 20 15:15
S6.1
Symposium 6: Precision Medicine for diabetes
Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Sun 20 15:45
S6.2
Symposium 6: Precision Medicine for diabetes
Can genetics improve precision medicine in diabetes?
Sun 20 16:15
S6.3
Symposium 6: Precision Medicine for diabetes
Precision nutrition in obesity: gene - diet interaction
Sun 20 15:15
S7.1
Symposium 7: Expanding the spectrum of thyroid hormone use
TRIAC Trial in Allan-Herndon-Dudley-Syndrome (MCT8)
Sun 20 15:45
S7.2
Symposium 7: Expanding the spectrum of thyroid hormone use
Tetrac as an antiangiogenic agent in cancer
Sun 20 16:15
S7.3
Symposium 7: Expanding the spectrum of thyroid hormone use
New applications of thyroid hormones, analogs, and metabolites in non-alcoholic fatty liver
Sun 20 15:15
S8.1
Symposium 8: Bone fragility – from bench to clinic
Clinical spectrum of new monogenic forms of osteoporosis
Helsinki, Finland
Sun 20 15:45
S8.2
Symposium 8: Bone fragility – from bench to clinic
What have we learnt from genome-wide association studies in osteoporosis
Sun 20 16:15
S8.3
Symposium 8: Bone fragility – from bench to clinic
Hypophosphatasia
Sun 20 15:15
S9.1
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Semen parameters as biomarkers of general health  
Copenhagen, Denmark
Sun 20 15:45
S9.2
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
The Klinefelter syndrome: a challenge for endocrinologists 
Münster, Germany
Sun 20 16:15
S9.3
Symposium 9: European academy of andrology/ESE Session: Male gonadal function versus general health and vice versa
Does "healthy obesity" exist in andrology? 
Sun 20 15:15
S10.1
Symposium 10: Hot topics in NETs
Whole Genome Landscape in pancreatic neuroendocrine tumours
Sun 20 15:45
S10.2
Symposium 10: Hot topics in NETs
Treatment of small intestine and pancreatic NETs what and when?
Sun 20 16:15
S10.3
Symposium 10: Hot topics in NETs
Treatment update on carcinoid syndrome and carcinoid heart disease
Sun 20 15:15
GL1.1
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Introduction to ENSAT Guidelines
Sun 20 15:20
GL1.2
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Methods
Sun 20 15:30
GL1.3
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Pathology & Prognostic factors
Sun 20 15:45
GL1.4
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Adjuvant therapy
Sun 20 16:00
GL1.5
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Therapy of advanced ACC
Sun 20 16:15
GL1.6
European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors
Special considerations on mitotane
Sun 20 18:00
Satellite Symposium
Mon 21 10:15
S11.1
Symposium 11: Novel aspects of Craniopharyngioma
Molecular Pathogenensis of Craniopharyngioma
London, UK
Mon 21 10:45
S11.2
Symposium 11: Novel aspects of Craniopharyngioma
Bariatric Surgery as Treatment in Craniopharyngioma
Mon 21 11:15
S11.3
Symposium 11: Novel aspects of Craniopharyngioma
Psychosocial dysfunction after treatment of of Craniopharyngioma
Mon 21 10:15
S12.1
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Increased fracture rate in diabetes and obesity      
Mon 21 10:45
S12.2
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Bone quality evaluation in Pituitary diseases
Mon 21 11:15
S12.3
Symposium 12: Why do fractures occur in endocrine disorders and how should they be handled?
Effect of parathyroid dysfunction on incidence of bone fractures
Mon 21 10:15
S13.1
Symposium 13: The colours of fat
Brown adipose tissue as an endocrine organ
Mon 21 10:45
S13.2
Symposium 13: The colours of fat
Adipose Tissue Browning in Mice and Men
Mon 21 11:15
S13.3
Symposium 13: The colours of fat
Brown Adipose Tissue Imaging
Mon 21 10:15
S14.1
Symposium 14: Neuroendocrine basis of reproductive disorders
Developmental wiring of GnRH neurons
Mon 21 10:45
S14.2
Symposium 14: Neuroendocrine basis of reproductive disorders
Neuroendocrinology right from the nose: genetics and pathophysiology of the olfacto-genital syndrome (Kallmann syndrome)
Mon 21 11:15
S14.3
Symposium 14: Neuroendocrine basis of reproductive disorders
Metabolic-reproductive interactions: From bench to bedside
Mon 21 10:15
S15.1
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Introduction to EYES
Mon 21 10:20
S15.2
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Metabolic reprogramming of cancer cells
Mon 21 10:40
S15.3
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Epigenetic and metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas
Mon 21 11:00
S15.4
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Immune Checkpoint Inhibitor Induced Hypophysitis – Experiences from the United Kingdom
Birmingham, UK
Mon 21 11:20
S15.5
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Alterations in Clock genes expression in human benign adrenal tumors
Mon 21 11:40
S15.6
Symposium 15: European Young Endocrine Scientists (EYES) New aspects in the study of neuroendocrine diseases
Invitation to EYES networking and annual meeting
Mon 21 14:00
Satellite symposium
Mon 21 14:00
Satellite symposium
Mon 21 14:00
Satellite symposium
Mon 21 15:15
S16.1
Symposium 16: Changing practice in the management of thyroid neoplasms
Genomic alterations in thyroid malignancies
Mon 21 15:45
S16.2
Symposium 16: Changing practice in the management of thyroid neoplasms
Composite approach in the evaluation and management of thyroid nodule
Mon 21 16:15
S16.3
Symposium 16: Changing practice in the management of thyroid neoplasms
New classification and guidelines in differentiated thryroid cancers
Mon 21 15:15
S17.1
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Adrenal development and benign tumor formation
Mon 21 15:45
S17.2
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Genetics of Primary Adrenal Macronodular Hyperplasia: when and what to test
Mon 21 16:15
S17.3
Symposium 17: Primary Adrenal Macronodular Hyperplasia
Diagnosis and management of Primary Adrenal Macronodular Hyperplasia
Mon 21 15:15
S18.1
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Sex hormones, obesity and type 2 diabetes – is there a link?
Mon 21 15:45
S18.2
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Relevant therapies in PCOS
Mon 21 16:15
S18.3
Symposium 18: Borderline testosterone and metabolic outcomes among sexes: clinical relevance
Testosterone, obesity and the metabolic syndrome in males – do we need to replace steroids?
Mon 21 15:15
S19.1
Symposium 19: New Aspects of Pituitary Regulation
Cytoskeleton and pharmacologic resistance in pituitary tumours
Mon 21 15:45
S19.2
Symposium 19: New Aspects of Pituitary Regulation
What fat does with your pituitary
Mon 21 16:15
S19.3
Symposium 19: New Aspects of Pituitary Regulation
How cancer treatment effects your pituitary
Mon 21 15:15
S20.1
Symposium 20: All you need to know about lipodystrophy
Insights in the pathogenesis of lipodystrophy
Mon 21 15:45
S20.2
Symposium 20: All you need to know about lipodystrophy
Acquired forms of lipodystrophy
Mon 21 16:15
S20.3
Symposium 20: All you need to know about lipodystrophy
Lipodystrophies, diagnosis and treatment: a step-by-step approach
Tue 22 09:45
S21.1
Symposium 21: The Dance of Adrenal and Gonads
The interplay Between the Ovaries and Adrenals
Tue 22 10:15
S21.2
Symposium 21: The Dance of Adrenal and Gonads
Management of phaeochromocytoma during pregnancy
London, UK
Tue 22 10:45
S21.3
Symposium 21: The Dance of Adrenal and Gonads
Fertility in Congenital Adrenal Hyperplasia
Tue 22 09:45
S22.1
Symposium 22: The fatty bone
Marrow adipose tissue and skeletal health
Tue 22 10:15
S22.2
Symposium 22: The fatty bone
Bone marrow adipose tissue: starving for attention?
Edinburgh , Scotland
Tue 22 10:45
S22.3
Symposium 22: The fatty bone
Cross-talk between bone marrow and periperal adipose tissue in man
Tue 22 09:45
S23.1
Symposium 23: Pre-diabetes
What have we learnt so far about the immunogenetics of type 1 diabetes?
Tue 22 10:15
S23.2
Symposium 23: Pre-diabetes
Prevention and treatment of pre type 1 diabetes
Tue 22 10:45
S23.3
Symposium 23: Pre-diabetes
Treatment of pre type 2 diabetes
Tue 22 09:45
S24.1
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
How Does Pituitary Release its Hormones?
Montpellier, France
Tue 22 10:15
S24.2
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
Peripheral Activities of Growth Hormone-Releasing Hormone (GHRH)
Tue 22 10:45
S24.3
Symposium 24: Ups and downs of hypothalamo-pituitary hormones
How Do Hypopituitary Patients Deal with Stress?
Tue 22 09:45
S25.1
Symposium 25: Late breaking
Microvesicles and exosomes: new players in metabolic diseases
Tue 22 10:15
S25.2
Symposium 25: Late breaking
Senescence-associated reprogramming promotes cancer stemness
Tue 22 10:45
S25.3
Symposium 25: Late breaking
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Tue 22 09:45
Endo-ERN: concrete examples of added value for patient care
Introduction, structure, and virtual consultation using the EU-ERN CPMS
Amsterdam, The Netherlands
Tue 22 10:00
Endo-ERN: concrete examples of added value for patient care
Caring for endocrinology across the life span: DSD and Hypogonadotropic hypogonadism
Lübeck, Germany
Tue 22 10:15
Endo-ERN: concrete examples of added value for patient care
Patient and family perspectives
Tue 22 14:45
S26.1
Symposium 26: Cortisol: Too much of a Good Thing
Genetics of Cushing's disease
Tue 22 15:15
S26.2
Symposium 26: Cortisol: Too much of a Good Thing
Hypercortisolism and the Brain
Tue 22 15:45
S26.3
Symposium 26: Cortisol: Too much of a Good Thing
Differentiating Cushing from Pseudo-Cushing
Tue 22 14:45
S27.1
Symposium 27: Emerging treatments in osteoporosis
Molecular basis of bone anabolism
Tue 22 15:15
S27.2
Symposium 27: Emerging treatments in osteoporosis
Novel therapies: PTH-related protein and sclerostin inhibition
Tue 22 15:45
S27.3
Symposium 27: Emerging treatments in osteoporosis
Sequential and combination therapy for osteoporosis
Tue 22 14:45
S28.1
Symposium 28: Endocrinology Meets Immunology
Concept of Immunotherapy in Cancer
Tue 22 15:15
S28.2
Symposium 28: Endocrinology Meets Immunology
Immunotherapy for Thyroid Carcinoma
Tue 22 15:45
S28.3
Symposium 28: Endocrinology Meets Immunology
Immunotherapy Related Endocrinopathies
Tue 22 14:45
S29.1
Symposium 29: Thyroid hormone action: regulation and clinical implications
Tissue-specific regulation of thyroid hormone action
Tue 22 15:15
S29.2
Symposium 29: Thyroid hormone action: regulation and clinical implications
Thyroid hormone economy in human aging
Leiden, The Netherlands
Tue 22 15:45
S29.3
Symposium 29: Thyroid hormone action: regulation and clinical implications
Elevated TSH in Children
Copenhagen, Denmark
Tue 22 14:45
S30.1
Symposium 30: Disorders of Sexual Development (DSD)
Long term consequences of Disorders of Sexual Development
Tue 22 15:15
S30.2
Symposium 30: Disorders of Sexual Development (DSD)
Atypical Genital Development and Hypospadias: a Pediatric Urology perspective from Etiology to Surgery
Tue 22 15:45
S30.3
Symposium 30: Disorders of Sexual Development (DSD)
Gender Dysphoria and Brain Function
Belgium
Sat 19 09:00
Pre-Congress Courses and Meetings
Sat 19 12:00
Registration
ENTRANCE HALL
Sat 19 20:15
Welcome Reception
EXHIBITION AREA
Sun 20 07:30
Registration
ENTRANCE HALL
Sun 20 09:00
Interview with the ESE president
AUDITORIUM
Sun 20
D2.1
Debate 2 - Receptor profiling is useful for predicting pituitary therapy
For - Receptor profiling is useful for predicting pituitary therapy
Sun 20
D2.2
Debate 2 - Receptor profiling is useful for predicting pituitary therapy
Against - Receptor profiling is useful for predicting pituitary therapy
Mon 21 07:30
Registration
ENTRANCE HALL
Tue 22 08:00
Registration
ENTRANCE HALL

0 result(s) found.